Friday, 29 March 2024


Quintiles acquires Novella, retains leadership team

17 September 2013 | News | By BioSpectrum Bureau

Novella will now be known as Novella Clinical, a Quintiles company. It will retaining its existing leadership team and operate as an unit within Quintiles

Novella will now be known as Novella Clinical, a Quintiles company. It will retaining its existing leadership team and operate as an unit within Quintiles

Singapore: Global CRO Quintiles has completed the acquisition of Novella Clinical, a full-service clinical research organization focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors.

With the transaction now officially closed, Novella will now focus its efforts on leveraging Quintiles' global resources and capabilities with the expertise and personal attention of Novella to continue to deliver the high-quality services customers have come to expect from both companies.

"We are extremely pleased to have completed the acquisition of Novella and look forward to working together to increase our collective opportunities with emerging oncology and medical device companies," said Ms Paula Brown Stafford, president, Clinical Development, Quintiles.

"With the transaction now officially closed, we will focus our efforts on leveraging Quintiles' global resources and capabilities with the expertise and personal attention of Novella to continue to deliver the high-quality services customers have come to expect from both companies," she added. 

Now known as Novella Clinical, a Quintiles company; Novella will operate as an unit within Quintiles, retaining its existing leadership team as well as its specialized customer focus.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account